Ludovic Pelligand

2.4k total citations
97 papers, 1.7k citations indexed

About

Ludovic Pelligand is a scholar working on Pharmacology, Small Animals and Molecular Medicine. According to data from OpenAlex, Ludovic Pelligand has authored 97 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pharmacology, 26 papers in Small Animals and 18 papers in Molecular Medicine. Recurrent topics in Ludovic Pelligand's work include Antibiotics Pharmacokinetics and Efficacy (36 papers), Antibiotic Resistance in Bacteria (18 papers) and Veterinary Pharmacology and Anesthesia (18 papers). Ludovic Pelligand is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (36 papers), Antibiotic Resistance in Bacteria (18 papers) and Veterinary Pharmacology and Anesthesia (18 papers). Ludovic Pelligand collaborates with scholars based in United Kingdom, France and United States. Ludovic Pelligand's co-authors include P. Lees, Pierre‐Louis Toutain, Jonathan Elliott, Alain Bousquet‐mélou, Aude Ferran, Timothy Potter, J. Illambas, Andrew N. Rycroft, Yu‐Mei Chang and Polly Taylor and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ludovic Pelligand

90 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ludovic Pelligand United Kingdom 26 639 431 307 270 237 97 1.7k
Dawn M. Boothe United States 28 542 0.8× 741 1.7× 553 1.8× 216 0.8× 328 1.4× 142 2.9k
Patricia M. Dowling Canada 18 276 0.4× 454 1.1× 98 0.3× 141 0.5× 166 0.7× 67 1.4k
J. Desmond Baggot United States 25 1.0k 1.6× 807 1.9× 224 0.7× 205 0.8× 190 0.8× 94 2.1k
W D Black Canada 24 307 0.5× 434 1.0× 171 0.6× 117 0.4× 175 0.7× 92 1.5k
Ronald Gronwall United States 21 483 0.8× 328 0.8× 127 0.4× 83 0.3× 132 0.6× 98 1.3k
Butch KuKanich United States 35 794 1.2× 2.0k 4.7× 87 0.3× 153 0.6× 503 2.1× 162 3.4k
Ted Whittem Australia 20 389 0.6× 1.0k 2.4× 45 0.1× 75 0.3× 443 1.9× 76 1.7k
Sangeeta Rao United States 24 223 0.3× 358 0.8× 50 0.2× 104 0.4× 228 1.0× 126 2.2k
Merran Govendir Australia 18 148 0.2× 256 0.6× 46 0.1× 134 0.5× 70 0.3× 81 924
Karol A. Mathews Canada 25 291 0.5× 834 1.9× 36 0.1× 54 0.2× 571 2.4× 57 1.9k

Countries citing papers authored by Ludovic Pelligand

Since Specialization
Citations

This map shows the geographic impact of Ludovic Pelligand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovic Pelligand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovic Pelligand more than expected).

Fields of papers citing papers by Ludovic Pelligand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludovic Pelligand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovic Pelligand. The network helps show where Ludovic Pelligand may publish in the future.

Co-authorship network of co-authors of Ludovic Pelligand

This figure shows the co-authorship network connecting the top 25 collaborators of Ludovic Pelligand. A scholar is included among the top collaborators of Ludovic Pelligand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludovic Pelligand. Ludovic Pelligand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toutain, Pierre‐Louis, et al.. (2025). Phenotype‐Specific Semi‐Mechanistic Modelling of Florfenicol Time‐Kill Curves in G. Parasuis Compared to Other Respiratory Pathogens. Journal of Veterinary Pharmacology and Therapeutics. 48(4). 318–339.
2.
Pelligand, Ludovic, et al.. (2024). Hollow-fibre infection model: adaptations for the culture and assessment of fastidious organisms. Access Microbiology. 6(6).
3.
Üzel, Mehmet, et al.. (2024). Population pharmacokinetics modelling for clinical dose adjustment of carboplatin in dogs. BMC Veterinary Research. 20(1). 575–575.
4.
Damborg, Peter, Fergus Allerton, Alain Bousquet‐mélou, et al.. (2024). ENOVAT: the European Network for Optimization of Veterinary Antimicrobial Treatment. SHILAP Revista de lepidopterología. 4. 170–170. 2 indexed citations
5.
Toutain, Pierre‐Louis, Peggy Gandia, Ludovic Pelligand, et al.. (2023). Biased computation of probability of target attainment for antimicrobial drugs. CPT Pharmacometrics & Systems Pharmacology. 12(5). 681–689. 8 indexed citations
6.
7.
Meller, Sebastian, Friederike Twele, Marios Charalambous, et al.. (2022). Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. Journal of Veterinary Internal Medicine. 36(5). 1726–1732. 7 indexed citations
8.
Packer, Rowena M. A., Annette Wessmann, Tarja S. Jokinen, et al.. (2020). A multicenter randomized controlled trial of medium-chain triglyceride dietary supplementation on epilepsy in dogs. Journal of Veterinary Internal Medicine. 34(3). 1248–1259. 35 indexed citations
9.
Chang, Yu‐Mei, S.M. Abeyesinghe, A. J. Fisher, et al.. (2019). Pregabalin for the treatment of syringomyelia-associated neuropathic pain in dogs: A randomised, placebo-controlled, double-masked clinical trial. The Veterinary Journal. 250. 55–62. 12 indexed citations
10.
Pelligand, Ludovic, et al.. (2019). Clinical utility of estimation of glomerular filtration rate in dogs. Journal of Veterinary Internal Medicine. 34(1). 195–205. 17 indexed citations
11.
Pelligand, Ludovic, et al.. (2019). Relationship between serum iohexol clearance, serum SDMA concentration, and serum creatinine concentration in non-azotemic dogs. Journal of Veterinary Internal Medicine. 34(1). 186–194. 33 indexed citations
12.
Martinez, Marilyn N., et al.. (2018). Population variability in animal health: Influence on dose‐exposure‐response relationships: PartII: Modelling and simulation. Journal of Veterinary Pharmacology and Therapeutics. 41(4). E68–E76. 8 indexed citations
13.
Toutain, Pierre‐Louis, Didier Concordet, Ronette Gehring, et al.. (2017). Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed‐effects to characterize and quantify variability in drug pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics. 41(2). 171–183. 54 indexed citations
14.
Toutain, Pierre‐Louis, Alain Bousquet‐mélou, Peter Damborg, et al.. (2017). En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach. Frontiers in Microbiology. 8. 2344–2344. 119 indexed citations
15.
16.
Jepson, Rosanne E., et al.. (2016). Factors Influencing the Relationship Between the Dose of Amlodipine Required for Blood Pressure Control and Change in Blood Pressure in Hypertensive Cats. Journal of Veterinary Internal Medicine. 30(5). 1630–1636. 15 indexed citations
17.
Pelligand, Ludovic, C. Thomas, Holger A. Volk, et al.. (2016). Dogs attending primary‐care practice in England with clinical signs suggestive of Chiari‐like malformation/syringomyelia. Veterinary Record. 179(17). 436–436. 18 indexed citations
18.
Pelligand, Ludovic, et al.. (2015). Neutrophil Gelatinase-Associated Lipocalin in Dogs With Sepsis Undergoing Emergency Laparotomy: A Prospective Case–Control Study. Journal of Veterinary Internal Medicine. 29(6). 1595–1602. 35 indexed citations
19.
Pelligand, Ludovic, Jonathan N. King, Wolfgang Seewald, et al.. (2015). Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney. BMC Veterinary Research. 11(1). 296–296. 16 indexed citations
20.
Potter, Timothy, J. Illambas, Ludovic Pelligand, Andrew N. Rycroft, & P. Lees. (2012). Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida. The Veterinary Journal. 195(1). 53–58. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dawn M. Boothe Breakdown of academic impact, for papers by Patricia M. Dowling Breakdown of academic impact, for papers by J. Desmond Baggot Breakdown of academic impact, for papers by W D Black Breakdown of academic impact, for papers by Ronald Gronwall Breakdown of academic impact, for papers by Butch KuKanich Breakdown of academic impact, for papers by Ted Whittem Breakdown of academic impact, for papers by Sangeeta Rao Breakdown of academic impact, for papers by Merran Govendir Breakdown of academic impact, for papers by Karol A. Mathews
Rankless by CCL
2026